PA HR220

Designates May 4-10, 2025, as "Tardive Dyskinesia Awareness Week" in Pennsylvania

Tardive dyskinesia (TD) is an involuntary movement disorder causing uncontrollable, repetitive movements of the face, torso, limbs, fingers, or toes, associated with prolonged use of dopamine receptor blocking agents (DRBAs)

Approximately 800,000 people in the United States are affected by TD, with an estimated 60% remaining undiagnosed

FDA-approved treatments for adults with TD now exist following clinical research

Encourages Pennsylvania residents and the broader public to become better informed about tardive dyskinesia symptoms and the importance of regular screenings for those taking DRBA medications